99 Episoade

  1. CSF proteomics in glioma

    Publicat: 21.03.2025

  2. Vorasidenib in IDH mutant glioma

    Publicat: 08.03.2025

  3. KL-50 in post TMZ MMR-deficient GBM

    Publicat: 22.02.2025

  4. Measurable disease per FET-PET vs MRI in GBM

    Publicat: 08.02.2025

  5. Pre-radiation chemotherapy in GBM

    Publicat: 20.01.2025

  6. cIMPACT-NOW Update 8: grading of meningiomas

    Publicat: 13.12.2024

  7. Residual tumor volume and survival after CCNU/TMZ in GBM

    Publicat: 24.11.2024

  8. Alterations in RNA splicing between meningioma DNA methylation groups

    Publicat: 08.11.2024

  9. The immune landscape of IDH mutant and IDHwt glioma

    Publicat: 25.10.2024

  10. Equity-driven applications of AI in neuro-oncology

    Publicat: 09.10.2024

  11. IDH mutant glioma across age groups

    Publicat: 20.09.2024

  12. Contemporary molecular prognostic signatures in glioma

    Publicat: 30.08.2024

  13. FDG PET in PCNSL

    Publicat: 09.08.2024

  14. TMZ and MGMT in elderly GBM patients

    Publicat: 12.07.2024

  15. IDH mutant glioma and IDH inhibitors

    Publicat: 05.07.2024

  16. Leptomeningeal disease, a SNO and ASCO review

    Publicat: 28.06.2024

  17. Cancer stems cell in GBM

    Publicat: 21.06.2024

  18. Drug delivery across the blood-brain barrier

    Publicat: 13.06.2024

  19. Gliomatosis cerebri in children

    Publicat: 24.05.2024

  20. Immunotherapy drives mesenchymal shift in GBM

    Publicat: 17.05.2024

1 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site